In AD brains, we saw a decrease in neuronal NeuN and an increase in glial fibrillary acidic protein (GFAP) (Fig 3A and Supporting Information Fig 1D) as indicators of neuronal loss and enhanced gliosis, respectively. Here, RBFOX3 is linked to Alzheimer disease.